AMA Update

AMA Update is your source for physician-focused news. Hear from physicians and other experts on trending public health concerns, practice issues, and more. Because who’s doing the talking matters.

AMA Update is your source for physician-focused news. Hear from physicians and other experts on trending public health concerns, practice issues, and more. Because who’s doing the talking matters.


All Episodes

AMA Update 159: Vaccine progress for kids under 5 & more with Andrea Garcia, JD, MPH

AMA CXO Todd Unger discusses the latest on COVID vaccines for fall with AMA Director of Science, Medicine and Public Health Andrea Garcia, JD, MPH. Also covering the vaccine rollout for kids under 5, as well as AMA’s statements on the U.S. Supreme Court decisions regarding firearm violence and overturning Roe v. Wade.

AMA Update 158: FDA and CDC back COVID vaccines for youngest kids with Andrea Garcia, JD, MPH

AMA CXO Todd Unger discusses the latest on COVID vaccines for kids under 5 with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering progress on Moderna’s and Pfizer’s EUAs, and identifying questions parents might have for physicians about getting their kids vaccinated.

AMA Update 157: Andrea Garcia, JD, MPH, on when the youngest kids can get vaccinated

AMA CXO Todd Unger discusses FDA timeline on Pfizer & Moderna vaccines for the youngest children with AMA Director of Science, Medicine and Public Health, Andrea Garcia. Also covering the FDA advisory committee’s recommendations for kids ages 6 to 17, news on a possible booster for fall, as well as the lifting of testing requirements for international travel to the U.S.

AMA Update 156: COVID vaccines for kids under 5 still pending with Andrea Garcia, JD, MPH

AMA CXO Todd Unger reviews the timeline for COVID vaccines for kids under 5 with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering COVID case numbers, what to expect this summer, how and why you should report positive at-home tests, as well as an increase in monkeypox cases in the U.S.

AMA Update 155: Fourth dose boosters and pediatric vaccines, an update with Peter Marks, MD, PhD from the FDA

Hear the latest on who should receive the fourth dose of the COVID-19 booster—and when—and whether we’ll be seeing a vaccine for younger children soon. Susan R. Bailey, MD, immediate past president, AMA welcomes Peter Marks, MD, PhD, Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration (FDA), addressing a host of hot topics related to the fourth dose booster vaccine and provide updates on pediatric vaccine safety data.

AMA Update 154: What doctors wish patients knew about COVID-19 testing with Emily Volk, MD, FCAP

On this episode, Emily Volk, MD, FCAP, president of the College of American Pathologists, talks about the ins and outs of COVID-19 testing; knowing when to test, what test to take, and other pressing questions patients may have.

AMA Update 153: COVID infections are increasing across the U.S. with Andrea Garcia, JD, MPH

AMA CXO Todd Unger reviews COVID-19 case trends coming out of the long weekend with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering Paxlovid treatments and «rebound infections,» monkeypox infections, and the AMA’s statement on the Texas elementary shootings that have devastated our nation.

AMA Update 152: Preliminary findings on COVID vaccine for kids under 5 with Andrea Garcia, JD, MPH

AMA CXO Todd Unger reviews the latest on vaccines for children ages 6 months through 4 years, as well as boosters for 5-11 year olds with AMA Director of Science, Medicine and Public Health, Andrea Garcia, JD, MPH. Also covering CDC’s recommendation on a second booster shot for people 50 or older, and the latest on the monkeypox outbreak.

AMA Update 151: Paxlovid side effects, treatment timelines and more with John Farley, MD, MPH

AMA CXO Todd Unger discusses what physicians and patients need to know about Paxlovid with John Farley, MD, MPH, director of the Office of Infectious Diseases in the Center for Drug Evaluation and Research’s Office of New Drugs at the FDA.

For more information on Paxlovid from the FDA, visit: https://www.fda.gov/drugs/news-events-human-drugs/fda-updates-paxlovid-health-care-providers